IntrinsicIntrinsic
← Scroll for more →

Financial Statements — NGNE

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents112.49124.16103.8571.0158.8170.77136.5966.63111.03150.14148.2125.2331.1135.4937.8940.3477.53128.06142.47154.92
Short-term Investments112.91119.02165.17194.41215.71221.83175.8272.3642.8719.3948.95------58.50----------
Total Current Assets228.91246.75271.77270.52278.99296.40315.92143.65159.15174.14200.3579.8983.7885.6499.13108.86118.49130.37143.99156.50
Property, Plant & Equipment11.7312.5012.7913.4814.2514.8115.4216.0716.0616.4817.170.480.562.496.165.826.246.236.456.26
Intangible Assets----------------------------0.000.000.020.070.130.18
Total Non-current Assets*15.4516.3916.8317.3118.3318.9019.8120.4720.6721.2122.239.6910.2312.8216.8117.7218.5418.7619.2719.44
Total Assets244.36263.14288.60287.83297.32315.30335.73164.12179.82195.35222.5789.5994.0198.46115.95126.58137.02149.13163.26175.93
Accounts Payable3.294.681.951.542.063.061.341.681.721.522.603.663.395.42--8.867.896.33--7.77
Total Current Liabilities21.5118.8716.4114.7115.4414.0915.1615.8013.0711.8222.975.214.887.1611.0610.249.277.608.649.00
Total Non-current Liabilities*5.736.497.317.588.629.4110.2010.9111.7412.7613.589.149.559.9510.5610.6911.0411.4411.7612.07
Total Liabilities27.2325.3623.7222.2924.0623.5125.3626.7124.8124.5736.5514.3514.4317.1021.6220.9320.3119.0320.4021.07
Retained Earnings(418.07)(383.58)(352.65)(327.91)(306.96)(284.94)(262.30)(242.78)(222.57)(204.07)(187.15)(471.87)(467.34)(465.26)(451.05)(437.61)(424.54)(408.85)(393.50)(378.33)
Total Stockholder Equity217.13237.78264.89265.54273.26291.80310.38137.41155.01170.78186.0275.2479.5881.3694.33105.65116.71130.09142.86154.87
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue----0.000.000.00--0.000.000.93--0.00------------------
Research & Development25.4725.1520.6417.2419.3717.7615.3516.2915.7413.5436.510.62(0.43)7.6910.009.4710.9610.70--9.90
Selling, General & Admin11.208.206.896.566.728.166.175.905.325.24(1.28)4.953.494.034.254.144.924.665.445.56
Total Operating Expenses36.6733.3527.5323.8026.0825.9221.5122.1821.0618.7831.815.573.0715.1414.2513.6115.87------
Operating Income(36.67)(33.35)(27.53)(23.80)(26.08)(25.92)(21.51)(22.18)(20.13)(18.78)(31.81)(5.57)(3.07)(15.13)(14.25)(13.61)(15.87)(15.36)(15.17)(15.45)
Interest Expense------------------0.00--------------------
Net Income(34.49)(30.93)(24.73)(20.95)(22.02)(22.65)(19.51)(20.22)(18.49)(16.92)(15.50)(4.53)(2.08)(14.20)(13.45)(13.07)(15.69)(15.35)(15.17)(15.45)
Basic EPS(1.53)(1.39)(1.12)(0.99)(1.05)(1.08)(1.00)(1.19)(1.09)(1.00)--(0.41)(0.04)(0.26)(0.24)(0.24)(0.28)(0.28)(0.28)(0.28)
Diluted EPS(1.53)(1.39)(1.12)(0.99)(1.05)(1.08)(1.00)(1.19)(1.09)(1.00)--(0.41)(0.04)(0.26)(0.24)(0.24)(0.28)(0.28)(0.28)(0.28)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(23.76)(26.12)(17.43)(19.51)(19.46)(20.77)(17.50)(15.56)(15.89)(21.65)(30.07)(4.27)(4.05)(13.03)(10.93)(9.29)(11.29)(14.09)(12.17)(8.76)
Capital Expenditures0.350.280.130.130.150.780.120.170.460.07(0.23)0.000.130.420.100.320.230.450.400.59
Free Cash Flow*(24.11)(26.40)(17.56)(19.64)(19.61)(21.55)(17.61)(15.73)(16.35)(21.71)(29.84)(4.27)(4.18)(13.45)(11.04)(9.61)(11.53)(14.54)(12.56)(9.34)
Investing Cash Flow6.1046.2429.6121.997.45(45.04)(102.62)(28.97)(23.61)29.9416.96(1.61)(0.41)10.718.47(27.85)(39.30)(0.45)(0.40)(0.59)
Financing Cash Flow5.980.2020.669.710.050.00190.070.130.40(6.52)92.84-0.00(0.29)(0.07)0.02(0.05)0.060.130.110.03
← Scroll for more columns →

* Derived from reported values